13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
SCHEDULE 13D Filed 2026-09-04 Event 2026-08-17 SEC 0001493152-26-041611 →

Lagoda Investment Management, L.P. VOLITIONRX LTD VNRX

Stake: 7.40% Shares: 1,652,005 CUSIP: 928661206 Class: Common Stock, par value $0.001 per share

Item 4 — Purpose of Transaction

The securities reported herein were originally acquired on behalf of the Accounts in the ordinary course of the Investment Manager's business for investment purposes and, at the time of acquisition, without any purpose or effect of changing or influencing control of the Issuer. Accordingly, the Investment Manager previously reported its beneficial ownership on Schedule 13G pursuant to Rule 13d-1(b). As described more fully below, the Reporting Persons now hold the securities reported herein with a purpose or effect that may be deemed to relate to changing or influencing control of the Issuer, and this Schedule 13D is accordingly being filed pursuant to Rule 13d-1(e). On or about August 17, 2026, Fatima Dickey delivered a letter to the Issuer's board of directors in which she expressed support for the Issuer's management and the long-term potential of the Issuer's intellectual property and products and recommended reductions in executive compensation and other operating expenses. The Reporting Persons do not currently intend to seek representation on the Issuer's board of directors. Subject to applicable law, the Reporting Persons reserve the right to acquire, or cause to be acquired, additional securities of the Issuer; to dispose of, or cause to be disposed of, any or all securities of the Issuer held in the Accounts; or to formulate other purposes, plans or proposals regarding the Issuer or any of its securities, in each case as they deem advisable in light of their general investment and trading policies, market conditions or other relevant factors. Except as set forth in this Schedule 13D, the Reporting Persons do not currently have any plan or proposal that relates to or would result in any of the matters described in paragraphs (a) through (j) of Item 4 of Schedule 13D, although they may, at any time and from time to time, review or reconsider their position, change their purpose or formulate plans or proposals with respect thereto.

Cross-References

Insider Activity (last 365d)
63 transactions
35 buys · 0 sales · 0 awards/exercises
Issuer Cluster
9 13D/G filings on this issuer
8 other filings besides this one
Filer Track Record
1 filings by this filer
0 other filings in the data moat
Short Interest · settle 2026-08-14
DTC 1.00
683,892 shares short · +27.0% vs prior

Form 4 Insider Transactions · last 365d

DateInsiderRoleTypeSharesPriceValue
2026-03-17 Forterre Gael officer F 5,251 $0.19 $998
2026-03-17 Rootsaert Rodney Gerard officer F 3,948 $0.19 $750
2026-03-17 Micallef Jacob Vincent officer F 5,310 $0.19 $1K
2026-03-17 Plummer Nicholas officer F 7,003 $0.19 $1K
2026-03-01 Rootsaert Rodney Gerard officer F 3,321 $0.21 $707
2026-03-01 Forterre Gael officer F 2,283 $0.21 $486
2026-03-01 Plummer Nicholas officer F 5,867 $0.21 $1K
2026-02-26 Forterre Gael officer Award 149,000
2026-02-26 Rubin Ethel director Award 178,000
2026-02-26 Reynolds Cameron John director, officer Award 486,000
2026-02-26 Batchelor Ann-Louise officer Award 142,000
2026-02-26 Hughes Terig officer Award 202,000
2026-02-26 Rootsaert Rodney Gerard officer Award 119,000
2026-02-26 Plummer Nicholas officer Award 187,000
2026-02-26 Nguyen Kim director Award 178,000
2026-02-26 Kway Jasmine officer Award 173,000
2026-02-26 Micallef Jacob Vincent officer Award 149,000
2026-02-26 Innes Guy Archibald director Award 178,000
2026-02-01 Forterre Gael officer F 2,010 $0.28 $573
2026-02-01 Rootsaert Rodney Gerard officer F 3,196 $0.28 $911
2026-02-01 Plummer Nicholas officer F 5,647 $0.28 $2K
2026-01-22 Rubin Ethel director Award 12,000
2026-01-22 Innes Guy Archibald director Award 12,000
2026-01-22 Forterre Gael officer Award 38,100
2026-01-22 Reynolds Cameron John director, officer Award 74,700
Showing 25 of 63

Other 13D/G Filings on VOLITIONRX LTD

FiledFormFilerStakeShares
2021-03-01 SC Faulkes Martin Charles view →
2021-03-01 SC Innes Guy Archibald view →
2021-03-01 SC Reynolds Cameron John view →
2020-07-09 SC Eight Corp Ltd view →
2020-06-10 SC Eight Corp Ltd view →
2020-06-10 SC Eight Corp Ltd view →
2020-06-02 SC Eight Corp Ltd view →
2019-02-11 SC Innes Guy Archibald view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →